FDA Approves Updated COVID-19 Vaccines for 2026-2027 Season

The Food and Drug Administration (FDA) has approved updated 2026-2027 COVID-19 vaccines from Moderna, Pfizer-BioNTech, and Novavax-Sanofi. These new formulations are designed to target the circulating XFG variant of the virus. The FDA has narrowed eligibility, primarily recommending vaccination for individuals aged 65 and older and younger Americans with underlying health conditions that increase the risk of severe COVID-19.